Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
9,220
archived clinical trials in
HIV / AIDS

A Prospective, Observational Study of Pregnancy Outcomes Among Women Exposed to Truvada for PrEP Indication
A Prospective, Observational Study of Pregnancy Outcomes Among Women Exposed to Truvada for PrEP Indication Nested in the Antiretroviral Pregnancy Registry
Status: Enrolling
Updated:  3/29/2018
Antiretroviral Pregnancy Registry
mi
from
Wilmington, NC
A Prospective, Observational Study of Pregnancy Outcomes Among Women Exposed to Truvada for PrEP Indication
A Prospective, Observational Study of Pregnancy Outcomes Among Women Exposed to Truvada for PrEP Indication Nested in the Antiretroviral Pregnancy Registry
Status: Enrolling
Updated: 3/29/2018
Antiretroviral Pregnancy Registry
mi
from
Wilmington, NC
Click here to add this to my saved trials
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) Infection
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute HCV in HIV-1 Infected Individuals (SWIFT-C)
Status: Enrolling
Updated:  3/29/2018
701 University of California, San Diego AntiViral Research Center CRS
mi
from
San Diego, CA
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) Infection
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute HCV in HIV-1 Infected Individuals (SWIFT-C)
Status: Enrolling
Updated: 3/29/2018
701 University of California, San Diego AntiViral Research Center CRS
mi
from
San Diego, CA
Click here to add this to my saved trials
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) Infection
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute HCV in HIV-1 Infected Individuals (SWIFT-C)
Status: Enrolling
Updated:  3/29/2018
801 University of California, San Francisco HIV/AIDS CRS
mi
from
San Francisco, CA
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) Infection
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute HCV in HIV-1 Infected Individuals (SWIFT-C)
Status: Enrolling
Updated: 3/29/2018
801 University of California, San Francisco HIV/AIDS CRS
mi
from
San Francisco, CA
Click here to add this to my saved trials
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) Infection
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute HCV in HIV-1 Infected Individuals (SWIFT-C)
Status: Enrolling
Updated:  3/29/2018
2701 Northwestern University CRS
mi
from
Chicago, IL
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) Infection
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute HCV in HIV-1 Infected Individuals (SWIFT-C)
Status: Enrolling
Updated: 3/29/2018
2701 Northwestern University CRS
mi
from
Chicago, IL
Click here to add this to my saved trials
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) Infection
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute HCV in HIV-1 Infected Individuals (SWIFT-C)
Status: Enrolling
Updated:  3/29/2018
101 Massachusetts General Hospital (MGH) CRS
mi
from
Boston, MA
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) Infection
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute HCV in HIV-1 Infected Individuals (SWIFT-C)
Status: Enrolling
Updated: 3/29/2018
101 Massachusetts General Hospital (MGH) CRS
mi
from
Boston, MA
Click here to add this to my saved trials
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) Infection
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute HCV in HIV-1 Infected Individuals (SWIFT-C)
Status: Enrolling
Updated:  3/29/2018
7804 Weill Cornell Chelsea CRS
mi
from
New York, NY
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) Infection
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute HCV in HIV-1 Infected Individuals (SWIFT-C)
Status: Enrolling
Updated: 3/29/2018
7804 Weill Cornell Chelsea CRS
mi
from
New York, NY
Click here to add this to my saved trials
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) Infection
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute HCV in HIV-1 Infected Individuals (SWIFT-C)
Status: Enrolling
Updated:  3/29/2018
7803 Weill Cornell Upton CRS
mi
from
New York, NY
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) Infection
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute HCV in HIV-1 Infected Individuals (SWIFT-C)
Status: Enrolling
Updated: 3/29/2018
7803 Weill Cornell Upton CRS
mi
from
New York, NY
Click here to add this to my saved trials
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) Infection
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute HCV in HIV-1 Infected Individuals (SWIFT-C)
Status: Enrolling
Updated:  3/29/2018
2401 Cincinnati CRS
mi
from
Cincinnati, OH
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) Infection
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute HCV in HIV-1 Infected Individuals (SWIFT-C)
Status: Enrolling
Updated: 3/29/2018
2401 Cincinnati CRS
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) Infection
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute HCV in HIV-1 Infected Individuals (SWIFT-C)
Status: Enrolling
Updated:  3/29/2018
6201 Penn Therapeutics CRS
mi
from
Philadelphia, PA
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) Infection
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute HCV in HIV-1 Infected Individuals (SWIFT-C)
Status: Enrolling
Updated: 3/29/2018
6201 Penn Therapeutics CRS
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) Infection
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute HCV in HIV-1 Infected Individuals (SWIFT-C)
Status: Enrolling
Updated:  3/29/2018
31443 Trinity Health and Wellness Center CRS
mi
from
Dallas, TX
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) Infection
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute HCV in HIV-1 Infected Individuals (SWIFT-C)
Status: Enrolling
Updated: 3/29/2018
31443 Trinity Health and Wellness Center CRS
mi
from
Dallas, TX
Click here to add this to my saved trials
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) Infection
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute HCV in HIV-1 Infected Individuals (SWIFT-C)
Status: Enrolling
Updated:  3/29/2018
31473 Houston AIDS Research Team (HART) CRS
mi
from
Houston, TX
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) Infection
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute HCV in HIV-1 Infected Individuals (SWIFT-C)
Status: Enrolling
Updated: 3/29/2018
31473 Houston AIDS Research Team (HART) CRS
mi
from
Houston, TX
Click here to add this to my saved trials
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) Infection
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute HCV in HIV-1 Infected Individuals (SWIFT-C)
Status: Enrolling
Updated:  3/29/2018
Whitman Walker Health CRS (31791)
mi
from
Washington,
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) Infection
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute HCV in HIV-1 Infected Individuals (SWIFT-C)
Status: Enrolling
Updated: 3/29/2018
Whitman Walker Health CRS (31791)
mi
from
Washington,
Click here to add this to my saved trials
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) Infection
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute HCV in HIV-1 Infected Individuals (SWIFT-C)
Status: Enrolling
Updated:  3/29/2018
Rush Univ. Med. Ctr. ACTG CRS (2702)
mi
from
Chicago, IL
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) Infection
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute HCV in HIV-1 Infected Individuals (SWIFT-C)
Status: Enrolling
Updated: 3/29/2018
Rush Univ. Med. Ctr. ACTG CRS (2702)
mi
from
Chicago, IL
Click here to add this to my saved trials
Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Human Immunodeficiency Virus (HIV)-Infected Subjects
Safety and Immunogenicity of GlaxoSmithKline Biologicals' Herpes Zoster Vaccine 1437173A in Adult HIV-infected Subjects
Status: Enrolling
Updated:  3/30/2018
GSK Investigational Site
mi
from
Long Beach, CA
Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Human Immunodeficiency Virus (HIV)-Infected Subjects
Safety and Immunogenicity of GlaxoSmithKline Biologicals' Herpes Zoster Vaccine 1437173A in Adult HIV-infected Subjects
Status: Enrolling
Updated: 3/30/2018
GSK Investigational Site
mi
from
Long Beach, CA
Click here to add this to my saved trials
Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Human Immunodeficiency Virus (HIV)-Infected Subjects
Safety and Immunogenicity of GlaxoSmithKline Biologicals' Herpes Zoster Vaccine 1437173A in Adult HIV-infected Subjects
Status: Enrolling
Updated:  3/30/2018
GSK Investigational Site
mi
from
San Francisco, CA
Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Human Immunodeficiency Virus (HIV)-Infected Subjects
Safety and Immunogenicity of GlaxoSmithKline Biologicals' Herpes Zoster Vaccine 1437173A in Adult HIV-infected Subjects
Status: Enrolling
Updated: 3/30/2018
GSK Investigational Site
mi
from
San Francisco, CA
Click here to add this to my saved trials
Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Human Immunodeficiency Virus (HIV)-Infected Subjects
Safety and Immunogenicity of GlaxoSmithKline Biologicals' Herpes Zoster Vaccine 1437173A in Adult HIV-infected Subjects
Status: Enrolling
Updated:  3/30/2018
GSK Investigational Site
mi
from
Orlando, FL
Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Human Immunodeficiency Virus (HIV)-Infected Subjects
Safety and Immunogenicity of GlaxoSmithKline Biologicals' Herpes Zoster Vaccine 1437173A in Adult HIV-infected Subjects
Status: Enrolling
Updated: 3/30/2018
GSK Investigational Site
mi
from
Orlando, FL
Click here to add this to my saved trials
Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Human Immunodeficiency Virus (HIV)-Infected Subjects
Safety and Immunogenicity of GlaxoSmithKline Biologicals' Herpes Zoster Vaccine 1437173A in Adult HIV-infected Subjects
Status: Enrolling
Updated:  3/30/2018
GSK Investigational Site
mi
from
Santa Fe, NM
Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Human Immunodeficiency Virus (HIV)-Infected Subjects
Safety and Immunogenicity of GlaxoSmithKline Biologicals' Herpes Zoster Vaccine 1437173A in Adult HIV-infected Subjects
Status: Enrolling
Updated: 3/30/2018
GSK Investigational Site
mi
from
Santa Fe, NM
Click here to add this to my saved trials
Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Human Immunodeficiency Virus (HIV)-Infected Subjects
Safety and Immunogenicity of GlaxoSmithKline Biologicals' Herpes Zoster Vaccine 1437173A in Adult HIV-infected Subjects
Status: Enrolling
Updated:  3/30/2018
GSK Investigational Site
mi
from
Dallas, TX
Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Human Immunodeficiency Virus (HIV)-Infected Subjects
Safety and Immunogenicity of GlaxoSmithKline Biologicals' Herpes Zoster Vaccine 1437173A in Adult HIV-infected Subjects
Status: Enrolling
Updated: 3/30/2018
GSK Investigational Site
mi
from
Dallas, TX
Click here to add this to my saved trials
Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Human Immunodeficiency Virus (HIV)-Infected Subjects
Safety and Immunogenicity of GlaxoSmithKline Biologicals' Herpes Zoster Vaccine 1437173A in Adult HIV-infected Subjects
Status: Enrolling
Updated:  3/30/2018
GSK Investigational Site
mi
from
Hannover,
Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Human Immunodeficiency Virus (HIV)-Infected Subjects
Safety and Immunogenicity of GlaxoSmithKline Biologicals' Herpes Zoster Vaccine 1437173A in Adult HIV-infected Subjects
Status: Enrolling
Updated: 3/30/2018
GSK Investigational Site
mi
from
Hannover,
Click here to add this to my saved trials
12 Weeks of Ledipasvir (LDV)/Sofosbuvir (SOF) With Weight-based Ribavirin vs. 24 Weeks of LDV/SOF
Phase II Trial of Retreatment Strategies for Difficult-to-Treat Hepatitis C Virus (HCV)-Infected Individuals Who Have Failed Prior Direct Acting Antiviral (DAA)-Based Regimens
Status: Enrolling
Updated:  4/2/2018
Ucsf Aids Crs (801)
mi
from
San Francisco, CA
12 Weeks of Ledipasvir (LDV)/Sofosbuvir (SOF) With Weight-based Ribavirin vs. 24 Weeks of LDV/SOF
Phase II Trial of Retreatment Strategies for Difficult-to-Treat Hepatitis C Virus (HCV)-Infected Individuals Who Have Failed Prior Direct Acting Antiviral (DAA)-Based Regimens
Status: Enrolling
Updated: 4/2/2018
Ucsf Aids Crs (801)
mi
from
San Francisco, CA
Click here to add this to my saved trials
12 Weeks of Ledipasvir (LDV)/Sofosbuvir (SOF) With Weight-based Ribavirin vs. 24 Weeks of LDV/SOF
Phase II Trial of Retreatment Strategies for Difficult-to-Treat Hepatitis C Virus (HCV)-Infected Individuals Who Have Failed Prior Direct Acting Antiviral (DAA)-Based Regimens
Status: Enrolling
Updated:  4/2/2018
7804 Weill Cornell Chelsea CRS
mi
from
New York, NY
12 Weeks of Ledipasvir (LDV)/Sofosbuvir (SOF) With Weight-based Ribavirin vs. 24 Weeks of LDV/SOF
Phase II Trial of Retreatment Strategies for Difficult-to-Treat Hepatitis C Virus (HCV)-Infected Individuals Who Have Failed Prior Direct Acting Antiviral (DAA)-Based Regimens
Status: Enrolling
Updated: 4/2/2018
7804 Weill Cornell Chelsea CRS
mi
from
New York, NY
Click here to add this to my saved trials
Medical Marijuana Use in HIV+ Patients Prospective Cohort Study
Behavioral Economic Analysis of Medical Marijuana Use in HIV+ Patients Prospective Cohort Study
Status: Enrolling
Updated:  4/3/2018
Wayne State University (HIV clinic, Tolan Park Medical Buiding)
mi
from
Detroit, MI
Medical Marijuana Use in HIV+ Patients Prospective Cohort Study
Behavioral Economic Analysis of Medical Marijuana Use in HIV+ Patients Prospective Cohort Study
Status: Enrolling
Updated: 4/3/2018
Wayne State University (HIV clinic, Tolan Park Medical Buiding)
mi
from
Detroit, MI
Click here to add this to my saved trials
Reducing Proviral HIV DNA With Interferon-a
Towards Eradication: Reducing Proviral HIV DNA With Interferon-a Immunotherapy
Status: Enrolling
Updated:  4/3/2018
Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
Reducing Proviral HIV DNA With Interferon-a
Towards Eradication: Reducing Proviral HIV DNA With Interferon-a Immunotherapy
Status: Enrolling
Updated: 4/3/2018
Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Reducing Proviral HIV DNA With Interferon-a
Towards Eradication: Reducing Proviral HIV DNA With Interferon-a Immunotherapy
Status: Enrolling
Updated:  4/3/2018
Penn-Presbyterian Hospital
mi
from
Philadelphia, PA
Reducing Proviral HIV DNA With Interferon-a
Towards Eradication: Reducing Proviral HIV DNA With Interferon-a Immunotherapy
Status: Enrolling
Updated: 4/3/2018
Penn-Presbyterian Hospital
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Reducing Proviral HIV DNA With Interferon-a
Towards Eradication: Reducing Proviral HIV DNA With Interferon-a Immunotherapy
Status: Enrolling
Updated:  4/3/2018
Jonathan Lax Center at Philadelphia FIGHT
mi
from
Philadelphia, PA
Reducing Proviral HIV DNA With Interferon-a
Towards Eradication: Reducing Proviral HIV DNA With Interferon-a Immunotherapy
Status: Enrolling
Updated: 4/3/2018
Jonathan Lax Center at Philadelphia FIGHT
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Multiplex Microarray Chip-Based Diagnosis of Respiratory Infections
Multiplex Microarray Chip-Based Diagnosis of Respiratory Infections
Status: Enrolling
Updated:  4/4/2018
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Multiplex Microarray Chip-Based Diagnosis of Respiratory Infections
Multiplex Microarray Chip-Based Diagnosis of Respiratory Infections
Status: Enrolling
Updated: 4/4/2018
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Gene Expression in HIV and Tuberculosis Co-infection
Transcriptional Signature of HIV And TB Co-Infection
Status: Enrolling
Updated:  4/4/2018
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Gene Expression in HIV and Tuberculosis Co-infection
Transcriptional Signature of HIV And TB Co-Infection
Status: Enrolling
Updated: 4/4/2018
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
A Demonstration Project to Add Pre- or Post-exposure Prophylaxis to Combination HIV Prevention Services
A Pilot Demonstration Project to Operationalize Pre-exposure Prophylaxis as Part of Combination HIV Prevention Among Men Who Have Sex With Men (MSM) and Transgender Women in Los Angeles County
Status: Enrolling
Updated:  4/4/2018
L.A. Gay & Lesbian Center
mi
from
Los Angeles, CA
A Demonstration Project to Add Pre- or Post-exposure Prophylaxis to Combination HIV Prevention Services
A Pilot Demonstration Project to Operationalize Pre-exposure Prophylaxis as Part of Combination HIV Prevention Among Men Who Have Sex With Men (MSM) and Transgender Women in Los Angeles County
Status: Enrolling
Updated: 4/4/2018
L.A. Gay & Lesbian Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Demonstration Project to Add Pre- or Post-exposure Prophylaxis to Combination HIV Prevention Services
A Pilot Demonstration Project to Operationalize Pre-exposure Prophylaxis as Part of Combination HIV Prevention Among Men Who Have Sex With Men (MSM) and Transgender Women in Los Angeles County
Status: Enrolling
Updated:  4/4/2018
Oasis Clinic
mi
from
Los Angeles, CA
A Demonstration Project to Add Pre- or Post-exposure Prophylaxis to Combination HIV Prevention Services
A Pilot Demonstration Project to Operationalize Pre-exposure Prophylaxis as Part of Combination HIV Prevention Among Men Who Have Sex With Men (MSM) and Transgender Women in Los Angeles County
Status: Enrolling
Updated: 4/4/2018
Oasis Clinic
mi
from
Los Angeles, CA
Click here to add this to my saved trials
CVCTPlus: A Couples-Based Approach to Linkage to Care and ARV Adherence
CVCTPlus: A Couples-Based Approach to Linkage to Care and ARV Adherence
Status: Enrolling
Updated:  4/6/2018
Rollins School of Public Health, Emory University
mi
from
Atlanta, GA
CVCTPlus: A Couples-Based Approach to Linkage to Care and ARV Adherence
CVCTPlus: A Couples-Based Approach to Linkage to Care and ARV Adherence
Status: Enrolling
Updated: 4/6/2018
Rollins School of Public Health, Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
CVCTPlus: A Couples-Based Approach to Linkage to Care and ARV Adherence
CVCTPlus: A Couples-Based Approach to Linkage to Care and ARV Adherence
Status: Enrolling
Updated:  4/6/2018
Children's Memorial Hospital
mi
from
Chicago, IL
CVCTPlus: A Couples-Based Approach to Linkage to Care and ARV Adherence
CVCTPlus: A Couples-Based Approach to Linkage to Care and ARV Adherence
Status: Enrolling
Updated: 4/6/2018
Children's Memorial Hospital
mi
from
Chicago, IL
Click here to add this to my saved trials
CVCTPlus: A Couples-Based Approach to Linkage to Care and ARV Adherence
CVCTPlus: A Couples-Based Approach to Linkage to Care and ARV Adherence
Status: Enrolling
Updated:  4/6/2018
Harvard School of Public Health
mi
from
Boston, MA
CVCTPlus: A Couples-Based Approach to Linkage to Care and ARV Adherence
CVCTPlus: A Couples-Based Approach to Linkage to Care and ARV Adherence
Status: Enrolling
Updated: 4/6/2018
Harvard School of Public Health
mi
from
Boston, MA
Click here to add this to my saved trials
CVCTPlus: A Couples-Based Approach to Linkage to Care and ARV Adherence
CVCTPlus: A Couples-Based Approach to Linkage to Care and ARV Adherence
Status: Enrolling
Updated:  4/6/2018
Fenway Health Institute
mi
from
Boston, MA
CVCTPlus: A Couples-Based Approach to Linkage to Care and ARV Adherence
CVCTPlus: A Couples-Based Approach to Linkage to Care and ARV Adherence
Status: Enrolling
Updated: 4/6/2018
Fenway Health Institute
mi
from
Boston, MA
Click here to add this to my saved trials
A Study of the Safety and Antiretroviral Activity of 3BNC117
An Open Label, Phase 2 Study of the Safety and Antiretroviral Activity of 3BNC117 in HIV-Infected Individuals on Combination Antiretroviral Therapy
Status: Enrolling
Updated:  4/10/2018
Rockefeller University
mi
from
New York, NY
A Study of the Safety and Antiretroviral Activity of 3BNC117
An Open Label, Phase 2 Study of the Safety and Antiretroviral Activity of 3BNC117 in HIV-Infected Individuals on Combination Antiretroviral Therapy
Status: Enrolling
Updated: 4/10/2018
Rockefeller University
mi
from
New York, NY
Click here to add this to my saved trials
A Study of the Safety and Antiretroviral Activity of 3BNC117
An Open Label, Phase 2 Study of the Safety and Antiretroviral Activity of 3BNC117 in HIV-Infected Individuals on Combination Antiretroviral Therapy
Status: Enrolling
Updated:  4/10/2018
Weill Cornel Medical Center
mi
from
New York, NY
A Study of the Safety and Antiretroviral Activity of 3BNC117
An Open Label, Phase 2 Study of the Safety and Antiretroviral Activity of 3BNC117 in HIV-Infected Individuals on Combination Antiretroviral Therapy
Status: Enrolling
Updated: 4/10/2018
Weill Cornel Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Support for Perinatal Adherence and Depression
Project INSPireD: Integrating Nuanced Support for Perinatal Adherence and Depression
Status: Enrolling
Updated:  4/10/2018
Massachusetts General Hospital
mi
from
Boston, MA
Support for Perinatal Adherence and Depression
Project INSPireD: Integrating Nuanced Support for Perinatal Adherence and Depression
Status: Enrolling
Updated: 4/10/2018
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Support for Perinatal Adherence and Depression
Project INSPireD: Integrating Nuanced Support for Perinatal Adherence and Depression
Status: Enrolling
Updated:  4/10/2018
MatCH Research
mi
from
Durban,
Support for Perinatal Adherence and Depression
Project INSPireD: Integrating Nuanced Support for Perinatal Adherence and Depression
Status: Enrolling
Updated: 4/10/2018
MatCH Research
mi
from
Durban,
Click here to add this to my saved trials
CHP 834 Unrelated and Partially Matched Related Donor Peripheral Stem Cell Transportation for T and B Cell Depletion
CHP 834 Unrelated and Partially Matched Related Donor Peripheral Stem Cell Transportation With the CliniMACs Device for T and B Cell Depletion
Status: Enrolling
Updated:  4/11/2018
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
CHP 834 Unrelated and Partially Matched Related Donor Peripheral Stem Cell Transportation for T and B Cell Depletion
CHP 834 Unrelated and Partially Matched Related Donor Peripheral Stem Cell Transportation With the CliniMACs Device for T and B Cell Depletion
Status: Enrolling
Updated: 4/11/2018
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Project FIRST - Financial Incentives to Reduce Substance Use and Improve Treatment
A Randomized Trial of an Abstinence-reinforcing Contingency Management Intervention to Suppress HIV Viral Load
Status: Enrolling
Updated:  4/19/2018
Montefiore's Community Clinics (Montefiore Medical Group)
mi
from
Bronx, NY
Project FIRST - Financial Incentives to Reduce Substance Use and Improve Treatment
A Randomized Trial of an Abstinence-reinforcing Contingency Management Intervention to Suppress HIV Viral Load
Status: Enrolling
Updated: 4/19/2018
Montefiore's Community Clinics (Montefiore Medical Group)
mi
from
Bronx, NY
Click here to add this to my saved trials
Project FIRST - Financial Incentives to Reduce Substance Use and Improve Treatment
A Randomized Trial of an Abstinence-reinforcing Contingency Management Intervention to Suppress HIV Viral Load
Status: Enrolling
Updated:  4/19/2018
Albert Einstein College of Medicine Division of Substance Abuse clinics
mi
from
Bronx, NY
Project FIRST - Financial Incentives to Reduce Substance Use and Improve Treatment
A Randomized Trial of an Abstinence-reinforcing Contingency Management Intervention to Suppress HIV Viral Load
Status: Enrolling
Updated: 4/19/2018
Albert Einstein College of Medicine Division of Substance Abuse clinics
mi
from
Bronx, NY
Click here to add this to my saved trials
Project FIRST - Financial Incentives to Reduce Substance Use and Improve Treatment
A Randomized Trial of an Abstinence-reinforcing Contingency Management Intervention to Suppress HIV Viral Load
Status: Enrolling
Updated:  4/19/2018
Montefiore Infectious Disease Clinic
mi
from
Bronx, NY
Project FIRST - Financial Incentives to Reduce Substance Use and Improve Treatment
A Randomized Trial of an Abstinence-reinforcing Contingency Management Intervention to Suppress HIV Viral Load
Status: Enrolling
Updated: 4/19/2018
Montefiore Infectious Disease Clinic
mi
from
Bronx, NY
Click here to add this to my saved trials
3BNC117 Monoclonal Antibody in HIV-infected Subjects During Treatment Interruption
A Phase 2, Open Label Study of the Safety, Antiretroviral Activity and Pharmacokinetics of 3BNC117 During a Short Analytical Treatment Interruption in HIV-infected Subjects
Status: Enrolling
Updated:  4/19/2018
Rockefeller University
mi
from
New York, NY
3BNC117 Monoclonal Antibody in HIV-infected Subjects During Treatment Interruption
A Phase 2, Open Label Study of the Safety, Antiretroviral Activity and Pharmacokinetics of 3BNC117 During a Short Analytical Treatment Interruption in HIV-infected Subjects
Status: Enrolling
Updated: 4/19/2018
Rockefeller University
mi
from
New York, NY
Click here to add this to my saved trials
Project RETAIN: Providing Integrated Care for HIV-Infected Crack Cocaine Users
Project RETAIN: Providing Integrated Care for HIV-Infected Crack Cocaine Users
Status: Enrolling
Updated:  4/20/2018
Jackson Health System-Special Immunology Clinic
mi
from
Miami, FL
Project RETAIN: Providing Integrated Care for HIV-Infected Crack Cocaine Users
Project RETAIN: Providing Integrated Care for HIV-Infected Crack Cocaine Users
Status: Enrolling
Updated: 4/20/2018
Jackson Health System-Special Immunology Clinic
mi
from
Miami, FL
Click here to add this to my saved trials
Project RETAIN: Providing Integrated Care for HIV-Infected Crack Cocaine Users
Project RETAIN: Providing Integrated Care for HIV-Infected Crack Cocaine Users
Status: Enrolling
Updated:  4/20/2018
Grady Health System Ponce De Leon Center
mi
from
Atlanta, GA
Project RETAIN: Providing Integrated Care for HIV-Infected Crack Cocaine Users
Project RETAIN: Providing Integrated Care for HIV-Infected Crack Cocaine Users
Status: Enrolling
Updated: 4/20/2018
Grady Health System Ponce De Leon Center
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Trial to Test the Efficacy of a Tailored Intensive Smoking Cessation Intervention in Persons With HIV (PWHs)
A Trial to Test the Efficacy of a Tailored Intensive Smoking Cessation Intervention in Persons With HIV (PWHs)
Status: Enrolling
Updated:  4/25/2018
Montefiore Medical Center
mi
from
Bronx, NY
A Trial to Test the Efficacy of a Tailored Intensive Smoking Cessation Intervention in Persons With HIV (PWHs)
A Trial to Test the Efficacy of a Tailored Intensive Smoking Cessation Intervention in Persons With HIV (PWHs)
Status: Enrolling
Updated: 4/25/2018
Montefiore Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
MK-8591 With Doravirine and Lamivudine in Participants Infected With Human Immunodeficiency Virus Type 1 (MK-8591-011)
A Phase 2B, Randomized, Double-Blind, Active-Comparator-Controlled, Dose-Ranging Clinical Trial to Evaluate the Safety, Tolerability, Antiretroviral Activity, and Pharmacokinetics of MK-8591 Given in Combination With Doravirine (DOR) and Lamivudine (3TC) in HIV-1-Infected Treatment-Naïve Adults
Status: Enrolling
Updated:  4/25/2018
Pueblo Family Physicians
mi
from
Phoenix, AZ
MK-8591 With Doravirine and Lamivudine in Participants Infected With Human Immunodeficiency Virus Type 1 (MK-8591-011)
A Phase 2B, Randomized, Double-Blind, Active-Comparator-Controlled, Dose-Ranging Clinical Trial to Evaluate the Safety, Tolerability, Antiretroviral Activity, and Pharmacokinetics of MK-8591 Given in Combination With Doravirine (DOR) and Lamivudine (3TC) in HIV-1-Infected Treatment-Naïve Adults
Status: Enrolling
Updated: 4/25/2018
Pueblo Family Physicians
mi
from
Phoenix, AZ
Click here to add this to my saved trials
MK-8591 With Doravirine and Lamivudine in Participants Infected With Human Immunodeficiency Virus Type 1 (MK-8591-011)
A Phase 2B, Randomized, Double-Blind, Active-Comparator-Controlled, Dose-Ranging Clinical Trial to Evaluate the Safety, Tolerability, Antiretroviral Activity, and Pharmacokinetics of MK-8591 Given in Combination With Doravirine (DOR) and Lamivudine (3TC) in HIV-1-Infected Treatment-Naïve Adults
Status: Enrolling
Updated:  4/25/2018
Northstar Medical Center
mi
from
Chicago, IL
MK-8591 With Doravirine and Lamivudine in Participants Infected With Human Immunodeficiency Virus Type 1 (MK-8591-011)
A Phase 2B, Randomized, Double-Blind, Active-Comparator-Controlled, Dose-Ranging Clinical Trial to Evaluate the Safety, Tolerability, Antiretroviral Activity, and Pharmacokinetics of MK-8591 Given in Combination With Doravirine (DOR) and Lamivudine (3TC) in HIV-1-Infected Treatment-Naïve Adults
Status: Enrolling
Updated: 4/25/2018
Northstar Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
MK-8591 With Doravirine and Lamivudine in Participants Infected With Human Immunodeficiency Virus Type 1 (MK-8591-011)
A Phase 2B, Randomized, Double-Blind, Active-Comparator-Controlled, Dose-Ranging Clinical Trial to Evaluate the Safety, Tolerability, Antiretroviral Activity, and Pharmacokinetics of MK-8591 Given in Combination With Doravirine (DOR) and Lamivudine (3TC) in HIV-1-Infected Treatment-Naïve Adults
Status: Enrolling
Updated:  4/25/2018
Kansas City Care Clinic
mi
from
Kansas City, MO
MK-8591 With Doravirine and Lamivudine in Participants Infected With Human Immunodeficiency Virus Type 1 (MK-8591-011)
A Phase 2B, Randomized, Double-Blind, Active-Comparator-Controlled, Dose-Ranging Clinical Trial to Evaluate the Safety, Tolerability, Antiretroviral Activity, and Pharmacokinetics of MK-8591 Given in Combination With Doravirine (DOR) and Lamivudine (3TC) in HIV-1-Infected Treatment-Naïve Adults
Status: Enrolling
Updated: 4/25/2018
Kansas City Care Clinic
mi
from
Kansas City, MO
Click here to add this to my saved trials
MK-8591 With Doravirine and Lamivudine in Participants Infected With Human Immunodeficiency Virus Type 1 (MK-8591-011)
A Phase 2B, Randomized, Double-Blind, Active-Comparator-Controlled, Dose-Ranging Clinical Trial to Evaluate the Safety, Tolerability, Antiretroviral Activity, and Pharmacokinetics of MK-8591 Given in Combination With Doravirine (DOR) and Lamivudine (3TC) in HIV-1-Infected Treatment-Naïve Adults
Status: Enrolling
Updated:  4/25/2018
North Texas Infectious Diseases Consultants, PA
mi
from
Dallas, TX
MK-8591 With Doravirine and Lamivudine in Participants Infected With Human Immunodeficiency Virus Type 1 (MK-8591-011)
A Phase 2B, Randomized, Double-Blind, Active-Comparator-Controlled, Dose-Ranging Clinical Trial to Evaluate the Safety, Tolerability, Antiretroviral Activity, and Pharmacokinetics of MK-8591 Given in Combination With Doravirine (DOR) and Lamivudine (3TC) in HIV-1-Infected Treatment-Naïve Adults
Status: Enrolling
Updated: 4/25/2018
North Texas Infectious Diseases Consultants, PA
mi
from
Dallas, TX
Click here to add this to my saved trials
MK-8591 With Doravirine and Lamivudine in Participants Infected With Human Immunodeficiency Virus Type 1 (MK-8591-011)
A Phase 2B, Randomized, Double-Blind, Active-Comparator-Controlled, Dose-Ranging Clinical Trial to Evaluate the Safety, Tolerability, Antiretroviral Activity, and Pharmacokinetics of MK-8591 Given in Combination With Doravirine (DOR) and Lamivudine (3TC) in HIV-1-Infected Treatment-Naïve Adults
Status: Enrolling
Updated:  4/25/2018
Saint Hope Foundation
mi
from
Bellaire, TX
MK-8591 With Doravirine and Lamivudine in Participants Infected With Human Immunodeficiency Virus Type 1 (MK-8591-011)
A Phase 2B, Randomized, Double-Blind, Active-Comparator-Controlled, Dose-Ranging Clinical Trial to Evaluate the Safety, Tolerability, Antiretroviral Activity, and Pharmacokinetics of MK-8591 Given in Combination With Doravirine (DOR) and Lamivudine (3TC) in HIV-1-Infected Treatment-Naïve Adults
Status: Enrolling
Updated: 4/25/2018
Saint Hope Foundation
mi
from
Bellaire, TX
Click here to add this to my saved trials